Ann Hematol (2017) 96:1577–1578 DOI 10.1007/s00277-017-3039-1 LETTER TO THE EDITOR Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p) 1 1 1 Marcelo Pitombeira de Lacerda & Nayara Ribeiro Guedes & Patricia Eiko Yamakawa & 1 1 Andre Domingues Pereira & Ana Rita Brito Medeiros da Fonseca & 1 1 Maria Lourdes Lopes Ferrari de Chauffaille & Matheus Vescovi Goncalves & 1 1 Mihoko Yamamoto & Celso Arrais Rodrigues Received: 7 May 2017 /Accepted: 26 May 2017 /Published online: 9 June 2017 Springer-Verlag Berlin Heidelberg 2017 Dear editor, weeks. After 3 months, he showed improvement of symptoms We present the case of a 68-year-old male with chronic lym- and sustained hemoglobin levels, with no transfusion require- phocytic leukemia (CLL). He was diagnosed with CLL in ment. His latest flow cytometry study showed 0.05% CLL September 2007 and del (17p) was detected by FISH. In cells in peripheral blood. No CMV reactivation occurred. 2008, due to progressive splenomegaly, he received six cycles Two episodes of neutropenia were observed, without fever of fludarabine and cyclophosphamide and achieved complete or documented infection, responding to venetoclax interrup- response. In July 2015, he relapsed with progressive lympho- tion
Annals of Hematology – Springer Journals
Published: Jun 9, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera